Catalent to Discuss how Drug Design Influences Patient Outcomes at PODD
Catalent, a leading global provider of advanced delivery technologies, development and manufacturing solutions for drugs,...
Flexible Manufacturing
Safinamide is the first new molecule in 20 years to be used in the treatment of Parkinson’s.
Zambon s.p.A. entrusted Catalent as its partner for timely development and launch of Safinamide under the brand name Xadago® to a worldwide target market.
More About This Company
Catalent to Discuss New Technologies at The Pharma Forum
Catalent, a leading global provider of advanced delivery technologies, development and manufacturing solutions for drugs,...
Catalent to Present at East Conference on September 9-12 2019
Catalent, a leading global provider of advanced delivery technologies, development and manufacturing solutions for drugs,...
The Use Of Continuous Chromatography In Effective Process Design Presentation
Catalent, a leading global provider of advanced delivery technologies and development and manufacturing solutions for...